Jefferies Reaffirms Their Buy Rating on South32 Ltd. (S32)
South32 Price Target Cut 20% to A$3.05/Share by Morgan Stanley
ResMed Price Target Raised to $204.00/Share From $200.00 by RBC Capital
South32 Ltd. (S32) Gets a Buy From Morgans
Macquarie Reaffirms Their Buy Rating on South32 Ltd. (S32)
South32 Price Target Cut 11% to A$4.00/Share by Macquarie
South32 Ltd. (S32) Gets a Buy From Barclays
Citi Reaffirms Their Hold Rating on South32 Ltd. (S32)
Analysts Offer Insights on Technology Companies: Atlassian (TEAM), Wisetech Global Ltd. (OtherWTCHF) and Genpact (G)
Goldman Sachs Starts Origin Energy at Buy With AU$11.35 Price Target
Jefferies Keeps Their Buy Rating on South32 Ltd. (S32)
International Consolidated Airlines (IAG) Gets a Buy From Goldman Sachs
Barclays Sticks to Their Buy Rating for South32 Ltd. (S32)
International Consolidated Airlines (IAG) Gets a Buy From Bernstein
Scentre Group (STGPF) Was Downgraded to a Sell Rating at UBS
Goldman Sachs Sticks to Their Hold Rating for Wisetech Global Ltd. (WTCHF)
Macquarie Keeps Their Buy Rating on South32 Ltd. (S32)
RBC Capital Markets Upgrades Xero to Outperform From Sector Perform, Price Target Is AU$155
Macquarie Upgrades Scentre Group to Outperform From Neutral, Price Target Is AU$3.37
Jarden Securities Upgrades Xero to Overweight From Neutral, Price Target Is AU$141.00